General Anxiety Disorder Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: GF469E48A695EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of General Anxiety Disorder Therapeutics in Global, including the following market information:

Global General Anxiety Disorder Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global General Anxiety Disorder Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Itriglumide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of General Anxiety Disorder Therapeutics include Bionomics Limited, Edgemont Pharmaceuticals, LLC and H. Lundbeck A/S, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the General Anxiety Disorder Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global General Anxiety Disorder Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global General Anxiety Disorder Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Itriglumide
• Tedatioxetine
• EDG-004
• Others

Global General Anxiety Disorder Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global General Anxiety Disorder Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global General Anxiety Disorder Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global General Anxiety Disorder Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies General Anxiety Disorder Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies General Anxiety Disorder Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bionomics Limited
• Edgemont Pharmaceuticals, LLC
• H. Lundbeck A/S

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 General Anxiety Disorder Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global General Anxiety Disorder Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENERAL ANXIETY DISORDER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global General Anxiety Disorder Therapeutics Market Size: 2021 VS 2028
2.2 Global General Anxiety Disorder Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top General Anxiety Disorder Therapeutics Players in Global Market
3.2 Top Global General Anxiety Disorder Therapeutics Companies Ranked by Revenue
3.3 Global General Anxiety Disorder Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 General Anxiety Disorder Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies General Anxiety Disorder Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 General Anxiety Disorder Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 General Anxiety Disorder Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 General Anxiety Disorder Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global General Anxiety Disorder Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Itriglumide
  4.1.3 Tedatioxetine
  4.1.4 EDG-004
  4.1.5 Others
4.2 By Type - Global General Anxiety Disorder Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global General Anxiety Disorder Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global General Anxiety Disorder Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global General Anxiety Disorder Therapeutics Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global General Anxiety Disorder Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global General Anxiety Disorder Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global General Anxiety Disorder Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global General Anxiety Disorder Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global General Anxiety Disorder Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global General Anxiety Disorder Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global General Anxiety Disorder Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America General Anxiety Disorder Therapeutics Revenue, 2017-2028
  6.3.2 US General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.3.3 Canada General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.3.4 Mexico General Anxiety Disorder Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe General Anxiety Disorder Therapeutics Revenue, 2017-2028
  6.4.2 Germany General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.4.3 France General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.4.4 U.K. General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.4.5 Italy General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.4.6 Russia General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.4.8 Benelux General Anxiety Disorder Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia General Anxiety Disorder Therapeutics Revenue, 2017-2028
  6.5.2 China General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.5.3 Japan General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.5.4 South Korea General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.5.6 India General Anxiety Disorder Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America General Anxiety Disorder Therapeutics Revenue, 2017-2028
  6.6.2 Brazil General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.6.3 Argentina General Anxiety Disorder Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa General Anxiety Disorder Therapeutics Revenue, 2017-2028
  6.7.2 Turkey General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.7.3 Israel General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia General Anxiety Disorder Therapeutics Market Size, 2017-2028
  6.7.5 UAE General Anxiety Disorder Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bionomics Limited
  7.1.1 Bionomics Limited Corporate Summary
  7.1.2 Bionomics Limited Business Overview
  7.1.3 Bionomics Limited General Anxiety Disorder Therapeutics Major Product Offerings
  7.1.4 Bionomics Limited General Anxiety Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Bionomics Limited Key News
7.2 Edgemont Pharmaceuticals, LLC
  7.2.1 Edgemont Pharmaceuticals, LLC Corporate Summary
  7.2.2 Edgemont Pharmaceuticals, LLC Business Overview
  7.2.3 Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Major Product Offerings
  7.2.4 Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Edgemont Pharmaceuticals, LLC Key News
7.3 H. Lundbeck A/S
  7.3.1 H. Lundbeck A/S Corporate Summary
  7.3.2 H. Lundbeck A/S Business Overview
  7.3.3 H. Lundbeck A/S General Anxiety Disorder Therapeutics Major Product Offerings
  7.3.4 H. Lundbeck A/S General Anxiety Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 H. Lundbeck A/S Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. General Anxiety Disorder Therapeutics Market Opportunities & Trends in Global Market
Table 2. General Anxiety Disorder Therapeutics Market Drivers in Global Market
Table 3. General Anxiety Disorder Therapeutics Market Restraints in Global Market
Table 4. Key Players of General Anxiety Disorder Therapeutics in Global Market
Table 5. Top General Anxiety Disorder Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global General Anxiety Disorder Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global General Anxiety Disorder Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies General Anxiety Disorder Therapeutics Product Type
Table 9. List of Global Tier 1 General Anxiety Disorder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 General Anxiety Disorder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - General Anxiety Disorder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - General Anxiety Disorder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - General Anxiety Disorder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - General Anxiety Disorder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global General Anxiety Disorder Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global General Anxiety Disorder Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bionomics Limited Corporate Summary
Table 31. Bionomics Limited General Anxiety Disorder Therapeutics Product Offerings
Table 32. Bionomics Limited General Anxiety Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Edgemont Pharmaceuticals, LLC Corporate Summary
Table 34. Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Product Offerings
Table 35. Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. H. Lundbeck A/S Corporate Summary
Table 37. H. Lundbeck A/S General Anxiety Disorder Therapeutics Product Offerings
Table 38. H. Lundbeck A/S General Anxiety Disorder Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. General Anxiety Disorder Therapeutics Segment by Type in 2021
Figure 2. General Anxiety Disorder Therapeutics Segment by Application in 2021
Figure 3. Global General Anxiety Disorder Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global General Anxiety Disorder Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global General Anxiety Disorder Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by General Anxiety Disorder Therapeutics Revenue in 2021
Figure 8. By Type - Global General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 12. US General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 24. China General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa General Anxiety Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE General Anxiety Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bionomics Limited General Anxiety Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. H. Lundbeck A/S General Anxiety Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)